Cargando…
Emerging Protein Biomarkers for the Diagnosis or Prediction of Gestational Diabetes—A Scoping Review
Introduction: Gestational diabetes (GDM), defined as hyperglycemia with onset or initial recognition during pregnancy, has a rising prevalence paralleling the rise in type 2 diabetes (T2DM) and obesity. GDM is associated with short-term and long-term consequences for both mother and child. Therefore...
Autores principales: | Bogdanet, Delia, Reddin, Catriona, Murphy, Dearbhla, Doheny, Helen C., Halperin, Jose A., Dunne, Fidelma, O’Shea, Paula M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038821/ https://www.ncbi.nlm.nih.gov/pubmed/33917484 http://dx.doi.org/10.3390/jcm10071533 |
Ejemplares similares
-
The utility of first trimester plasma glycated CD59 (pGCD59) in predicting gestational diabetes mellitus: A prospective study of non-diabetic pregnant women in Ireland
por: Bogdanet, Delia, et al.
Publicado: (2022) -
The Diagnostic Accuracy of Second Trimester Plasma Glycated CD59 (pGCD59) to Identify Women with Gestational Diabetes Mellitus Based on the 75 g OGTT Using the WHO Criteria: A Prospective Study of Non-Diabetic Pregnant Women in Ireland
por: Bogdanet, Delia, et al.
Publicado: (2022) -
Plasma glycated CD59 (gCD59), a novel biomarker for the diagnosis, management and follow up of women with Gestational Diabetes (GDM) – protocol for prospective cohort study
por: Bogdanet, D., et al.
Publicado: (2020) -
The ability of pGCD59 to predict adverse pregnancy outcomes: a prospective study of non-diabetic pregnant women in Ireland
por: Bogdanet, Delia, et al.
Publicado: (2022) -
The Oral Glucose Tolerance Test—Is It Time for a Change?—A Literature Review with an Emphasis on Pregnancy
por: Bogdanet, Delia, et al.
Publicado: (2020)